Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01205048 · ClinicalTrials.gov registry record · NA
Emervel Classic Lidocaine Versus Juvederm® Ultra in Treatment of Moderate to Severe Facial Wrinkles and Folds
A NA study, sponsored by Galderma R&D.
- Completed
- Registry status
- NA
- Development phase
- 171
- Enrollment target
NCT01205048 is a NA study that has completed, run by Galderma R&D. The registered enrollment target is 171 participants.
The verdict
NCT01205048, a NA study, has completed, sponsored by Galderma R&D.
- COMPLETED
- Registry status
- NA
- Development phase
- 171 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the effectiveness and safety of Emervel Classic Lidocaine versus Juvederm® Ultra in the treatment of moderate to severe facial wrinkles and folds.
Interventions
- DEVICE Emervel Classic Lidocaine
- DEVICE Juvederm® Ultra
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 171 participants |
| Start Date | 2010-09 |
| Est. Completion | 2012-01-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01205048
The ClinicalTrials.gov registry entry for NCT01205048 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 171 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Galderma R&D, which has 158 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Emervel Classic Lidocaine is the first listed.
NCT01205048 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01205048 about?
NCT01205048 is a clinical study titled "Emervel Classic Lidocaine Versus Juvederm® Ultra in Treatment of Moderate to Severe Facial Wrinkles and Folds". The purpose of this study is to compare the effectiveness and safety of Emervel Classic Lidocaine versus Juvederm® Ultra in the treatment of moderate to severe facial wrinkles and folds.
What is the current status of trial NCT01205048?
This trial is currently completed. It is a NA study. The enrollment target is 171 participants. The study started on 2010-09. Estimated completion is 2012-01-19.
What interventions are being tested in trial NCT01205048?
The interventions under investigation include: Emervel Classic Lidocaine (DEVICE), Juvederm® Ultra (DEVICE).
Who is sponsoring clinical trial NCT01205048?
This trial is sponsored by Galderma R&D, which has 158 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.